Contents of this document
- Strategic partnership with RSCM, Indonesia's largest national hospital, in the field of ophthalmology
- Launch of the AI management support service “Mirucoms” for home-visit nursing care providers
- Execution of an agreement to tender shares and sell them in HYUGA PRIMARY CARE株式会社's tender offer for its own shares
- Number of major domestic support locations171 LocationYear on year against the same period last year162 locations in the same period of the previous year
- Number of U.S. locations42 LocationYear on year against the same period last year34 locations in the same period of the previous year
- Number of U.S. patients65,326 peopleYear on year against the same period last year69,695 people in the same period of the previous year
- Number of hospice facilities68 FacilityYear on year against the same period last year54 facilities in the same period of the previous year
- Number of home-visit nursing users15,866 peopleYear on year against the same period last year15,012 people in the same period of the previous year
- Total home-visit nursing care hours342 Thousand hoursYear on year against the same period last year324 thousand hours in the same period of the previous year
- Medical Care Residence occupancy rate76.1 %Year on year against the same period last year77.3% in the same period of the previous year
| Item | Details |
|---|---|
| Document type | Results presentation |
| Fiscal Period Covered | Second quarter of the fiscal year ending March 2027 |
| Net Sales | ¥28,735 million (YoY +9.3%) |
| Operating profit | ¥947 million (YoY -44.7%) |
| Net income | ¥-101 million |
| Results for the three months of the current quarter | Revenue ¥14,576 million / EBITDA ¥1,896 million |
| Full-year earnings forecast | Revenue ¥64,600 million / EBITDA ¥9,700 million / Operating profit ¥3,800 million / Profit for the period attributable to owners of the parent ¥1,100 million |
| Progress against full-year forecast | Revenue 44.5% (consolidated), medical institutions 45.9%, domestic 51.3%, overseas 40.2%, hospice 42.1%, home-visit nursing care 48.4%, medical care residences 46.5% / EBITDA 32.2% (consolidated), medical institutions 43.1%, domestic 57.1%, hospice 24.8%, home-visit nursing care 38.5%, medical care residences 31.7% / Operating profit 24.9% (consolidated), medical institutions 55.2%, domestic 58.3%, home-visit nursing care 42.2% / Profit for the period attributable to owners of the parent Progress rate not stated |
| Self-assessment against the plan | Revenue is below plan, but profit is broadly in line with plan |
| Segment results | Medical institutions Revenue ¥9,544 million (YoY +16.0%) / EBITDA ¥1,744 million (YoY -3.8%) / Hospice Revenue ¥8,644 million (YoY +8.9%) / EBITDA ¥607 million (YoY -25.1%) / Home-Visit Nursing Revenue ¥6,732 million (YoY +3.3%) / EBITDA ¥597 million (YoY -31.4%) / Medical Care Residences Revenue ¥3,880 million (YoY +7.2%) / EBITDA ¥681 million (YoY +19.4%) |
| Breakdown of Factors Affecting the Change | Revenue, YoY Medical institutions in Japan 288 / Medical institutions overseas 22 / Hospice 675 / Home-Visit Nursing 61 / Medical Care Residences 589 / Other and adjustments 57 / EBITDA, YoY Medical institutions in Japan 288 / Medical institutions overseas -344 / Hospice -164 / Home-Visit Nursing -224 / Medical Care Residences 111 / Other and adjustments -47 |
| Key KPIs | Indicator name Number of major domestic support locations / Value 171 Location / Year on year against the same period last year 162 locations in the same period of the previous year, Indicator name Number of U.S. locations / Value 42 Location / Year on year against the same period last year 34 locations in the same period of the previous year, Indicator name Number of U.S. patients / Value 65,326 people / Year on year against the same period last year 69,695 people in the same period of the previous year, Indicator name Number of hospice facilities / Value 68 Facility / Year on year against the same period last year 54 facilities in the same period of the previous year, Indicator name Number of home-visit nursing users / Value 15,866 people / Year on year against the same period last year 15,012 people in the same period of the previous year, Indicator name Total home-visit nursing care hours / Value 342 Thousand hours / Year on year against the same period last year 324 thousand hours in the same period of the previous year, Indicator name Medical Care Residence occupancy rate / Value 76.1 % / Year on year against the same period last year 77.3% in the same period of the previous year |
| Unit price and quantity metrics | United States Number of patients 65,326 People, yen / Revenue per patient 31,715 People, yen / Hospice Annual revenue per resident ¥7.3 million / Medical Care Residences Annual revenue per resident ¥5 million |
| Number of stores and locations | Number of key locations supporting medical institutions in Japan 171 / Number of U.S. medical institution locations 42 / Number of hospice facilities 68 / Home-visit nursing location count 102 / Medical care residence facility count 27 / Number of store openings and closures during the period Home-visit nursing care opened 7 new locations in Q1 of the fiscal year ending March 2027. Hospice increased by 14 facilities year on year. Other openings and closures: Not disclosed |
| Assumptions Underlying the Business Outlook | Fiscal year ending March 2027 forecast exchange rate Approximately ¥155 to the U.S. dollar (average for the period) / Fiscal year ending March 2027, Q2 actual exchange rate Approximately ¥159 to the U.S. dollar (average for the period) |
| New initiatives | Strategic partnership with RSCM, Indonesia's largest national hospital, in the field of ophthalmology, Launch of the AI management support service “Mirucoms” for home-visit nursing care providers, Execution of an agreement to tender shares and sell them in HYUGA PRIMARY CARE株式会社's tender offer for its own shares |
Items this document does not state (15)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue was driven by an increase in the number of major domestic medical institution support locations, improved utilization at new hospice facilities and an increase in users resulting from additional staff in home-visit nursing care. On the other hand, profit was reduced by lower hospice fees following the revision of medical service fees, upfront investment in the U.S. OBL business, and initial losses associated with the early hiring of staff for home-visit nursing care and the opening of 7 new locations.